Multimodality imaging of pancreatic ductal adenocarcinoma: A review of the literature

HPB

Volumn 14, Issue 10, 2012, Pages 658-668

  Shrikhande, Shailesh V ^a   Barreto, Savio George ^a   Goel, Mahesh ^a   Arya, Supreeta ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84866099262     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00508.x     Document Type: Review

References (90)

1. Cancer Facts and Figures. (2009) American Cancer Society. Available at http://www.cancer.org/acs/groups/content/@nho/documents/document/500809webpdf. pdf (last accessed 8 June 2012).
2. Cancer Research UK. Available at http://info.cancerresearchuk.org/ cancerstats/types/pancreas/incidence/ (last accessed 8 June 2012).
3. Chen KX, Wang PP, Zhang SW, Li LD, Lu FZ, Hao XS,. (2003) Regional variations in mortality rates of pancreatic cancer in China: results from 1990-1992 national mortality survey. World J Gastroenterol 9: 2557-2560.
4. Seino T, Nakadaira H, Endoh K, Yamamoto M,. (2008) Changes in pancreatic cancer mortality, period patterns, and birth cohort patterns in Japan: analysis of mortality data in the period 1968-2002. Environ Health Prev Med 13: 234-242.
5. Paez D, Labonte M, Lenz H,. (2012) Pancreatic Cancer: medical management (novel chemotherapeutics). Gastroenterol Clin North Am 41: 189-209.
6. Shukla PJ, Barreto SG, Kulkarni A, Nagarajan G, Fingerhut A,. (2010) Vascular anomalies encountered during pancreatoduodenectomy: do they influence outcomes? Ann Surg Oncol 17: 186-193.
7. Dickersin K, Scherer R, Lefebvre C,. (1994) Identifying relevant studies for systematic reviews. BMJ 309: 1286-1291.
8. Karlson BM, Ekbom A, Lindgren PG, Kallskog V, Rastad J,. (1999) Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. Radiology 213: 107-111.
9. Koito K, Namieno T, Nagakawa T, Morita K,. (1997) Inflammatory pancreatic masses: differentiation from ductal carcinomas with contrast-enhanced sonography using carbon dioxide microbubbles. AJR Am J Roentgenol 169: 1263-1267.
10. Morrin MM, Kruskal JB, Raptopoulos V, Weisinger K, Farrell RJ, Steer ML, et al,. (2001) State-of-the-art ultrasonography is as accurate as helical computed tomography and computed tomographic angiography for detecting unresectable periampullary cancer. J Ultrasound Med 20: 481-490.
11. Bluemke DA, Cameron JL, Hruban RH, Pitt HA, Siegelman SS, Soyer P, et al,. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197: 381-385.
12. Brennan DD, Zamboni GA, Raptopoulos VD, Kruskal JB,. (2007) Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT. Radiographics 27: 1653-1666.
13. Bronstein YL, Loyer EM, Kaur H, Choi H, David C, DuBrow RA, et al,. (2004) Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 182: 619-623.
14. Brugel M, Rummeny EJ, Dobritz M,. (2004) Vascular invasion in pancreatic cancer: value of multislice helical CT. Abdom Imaging 29: 239-245.
15. Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M,. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 206: 373-378.
16. Fletcher JG, Wiersema MJ, Farrell MA, Fidler JL, Burgart LJ, Koyama T, et al,. (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229: 81-90.
17. Graf O, Boland GW, Warshaw AL, Fernandez-del-Castillo C, Hahn PF, Mueller PR,. (1997) Arterial versus portal venous helical CT for revealing pancreatic adenocarcinoma: conspicuity of tumor and critical vascular anatomy. AJR Am J Roentgenol 169: 119-123.
18. Imbriaco M, Megibow AJ, Ragozzino A, Liuzzi R, Mainenti P, Bortone S, et al,. (2005) Value of the single-phase technique in MDCT assessment of pancreatic tumors. AJR Am J Roentgenol 184: 1111-1117.
19. Kaneko OF, Lee DM, Wong J, Kadell BM, Reber HA, Lu DS, et al,. (2010) Performance of multidetector computed tomographic angiography in determining surgical resectability of pancreatic head adenocarcinoma. J Comput Assist Tomogr 34: 732-738.
20. Karmazanovsky G, Fedorov V, Kubyshkin V, Kotchatkov A,. (2005) Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging 30: 488-500.
21. Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, et al,. (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206: 833-846. discussion 46-8.
22. Kent TS, Raptopoulos V, Callery MP, Gautam S, Vollmer CM,. (2010) Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasms. HPB 12: 115-122.
23. Kim YE, Park MS, Hong HS, Kang CM, Choi JY, Lim JS, et al,. (2009) Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer. Radiology 250: 758-765.
24. Kinney T,. (2010) Evidence-based imaging of pancreatic malignancies. Surg Clin North Am 90: 235-249.
25. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J,. (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 168: 1439-1443.
26. McNulty NJ, Francis IR, Platt JF, Cohan RH, Korobkin M, Gebremariam A,. (2001) Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220: 97-102.
27. O'Malley ME, Boland GW, Wood BJ, Fernandez-del Castillo C, Warshaw AL, Mueller PR,. (1999) Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol 173: 1513-1518.
28. Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB, Jr,. (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224: 764-768.
29. Shrikhande SV, Arya S, Barreto SG, Ingle S, D'Souza MA, Hawaldar R, et al,. (2011) Borderline resectable pancreatic tumors: is there a need for further refinement of this stage? Hepatobiliary Pancreat Dis Int 10: 319-324.
30. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al,. (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13: 1035-1046.
31. Varadhachary GR, Tamm EP, Crane C, Evans DB, Wolff RA,. (2005) Borderline resectable pancreatic cancer. Curr Treat Options Gastroenterol 8: 377-384.
32. Zamboni GA, Kruskal JB, Vollmer CM, Baptista J, Callery MP, Raptopoulos VD,. (2007) Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation. Radiology 245: 770-778.
33. Zhao WY, Luo M, Sun YW, Xu Q, Chen W, Zhao G, et al,. (2009) Computed tomography in diagnosing vascular invasion in pancreatic and periampullary cancers: a systematic review and meta-analysis. Hepatobiliary Pancreat Dis Int 8: 457-464.
34. Hanninen EL, Pech M, Jonas S, Ricke J, Thelen A, Langrehr J, et al,. (2005) Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol 46: 462-470.
35. Hochwald SN, Rofsky NM, Dobryansky M, Shamamian P, Marcus SG,. (1999) Magnetic resonance imaging with magnetic resonance cholangiopancreatography accurately predicts resectability of pancreatic carcinoma. J Gastrointest Surg 3: 506-511.
36. Megibow AJ, Zhou XH, Rotterdam H, Francis IR, Zerhouni EA, Balfe DM, et al,. (1995) Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability-report of the Radiology Diagnostic Oncology Group. Radiology 195: 327-332.
37. Tapper EB, Martin D, Adsay NV, Kooby D, Kalb B, Sarmiento JM,. (2010) An MRI-driven practice: a new perspective on MRI for the evaluation of adenocarcinoma of the head of the pancreas. J Gastrointest Surg 14: 1292-1297.
38. Hariharan D, Constantinides VA, Froeling FE, Tekkis PP, Kocher HM,. (2010) The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of pancreatico-biliary cancers-a meta-analysis. Eur J Surg Oncol 36: 941-948.
39. Shoup M, Winston C, Brennan MF, Bassman D, Conlon KC,. (2004) Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma? J Gastrointest Surg 8: 1068-1071.
40. Buck AC, Schirrmeister HH, Guhlmann CA, Diederichs CG, Shen C, Buchmann I, et al,. (2001) Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity? J Nucl Med 42: 721-725.
41. Diederichs CG, Staib L, Vogel J, Glasbrenner B, Glatting G, Brambs HJ, et al,. (2000) Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20: 109-116.
42. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME,. (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42: 1S-93S.
43. Imdahl A, Nitzsche E, Krautmann F, Hogerle S, Boos S, Einert A, et al,. (1999) Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D- glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg 86: 194-199.
44. Kauhanen SP, Komar G, Seppanen MP, Dean KI, Minn HR, Kajander SA, et al,. (2009) A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg 250: 957-963.
45. Lee TY, Kim MH, Park do H, Seo DW, Lee SK, Kim JS, et al,. (2009) Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol 193: 343-348.
46. Ozaki Y, Oguchi K, Hamano H, Arakura N, Muraki T, Kiyosawa K, et al,. (2008) Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 43: 144-151.
47. Pakzad F, Groves AM, Ell PJ,. (2006) The role of positron emission tomography in the management of pancreatic cancer. Semin Nucl Med 36: 248-256.
48. van Kouwen MC, Jansen JB, van Goor H, de Castro S, Oyen WJ, Drenth JP,. (2005) FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging 32: 399-404.
49. Fisher L, Segarajasingam DS, Stewart C, Deboer WB, Yusoff IF,. (2009) Endoscopic ultrasound guided fine needle aspiration of solid pancreatic lesions: performance and outcomes. J Gastroenterol Hepatol 24: 90-96.
50. Owens DJ, Savides TJ,. (2010) Endoscopic ultrasound staging and novel therapeutics for pancreatic cancer. Surg Oncol Clin N Am 19: 255-266.
51. Tadic M, Kujundzic M, Stoos-Veic T, Kaic G, Vukelic-Markovic M,. (2008) Role of repeated endoscopic ultrasound-guided fine needle aspiration in small solid pancreatic masses with previous indeterminate and negative cytological findings. Dig Dis. 26: 377-382.
52. Kitano M, Kudo M, Maekawa K, Suetomi Y, Sakamoto H, Fukuta N, et al,. (2004) Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53: 854-859.
53. Fusari M, Maurea S, Imbriaco M, Mollica C, Avitabile G, Soscia F, et al,. (2010) Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses. Radiol Med 115: 453-466.
54. Cannon ME, Carpenter SL, Elta GH, Nostrant TT, Kochman ML, Ginsberg GG, et al,. (1999) EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc 50: 27-33.
55. Chen CH, Yang CC, Yeh YH, Chou DA, Nien CK,. (2009) Reappraisal of endosonography of ampullary tumors: correlation with transabdominal sonography, CT, and MRI. J Clin Ultrasound 37: 18-25.
56. Howard TJ, Chin AC, Streib EW, Kopecky KK, Wiebke EA,. (1997) Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg 174: 237-241.
57. Midwinter MJ, Beveridge CJ, Wilsdon JB, Bennett MK, Baudouin CJ, Charnley RM,. (1999) Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 86: 189-193.
58. Rivadeneira DE, Pochapin M, Grobmyer SR, Lieberman MD, Christos PJ, Jacobson I, et al,. (2003) Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary malignancies. Ann Surg Oncol 10: 890-897.
59. Rosch T, Lorenz R, Braig C, Feuerbach S, Siewert JR, Schusdziarra V, et al,. (1991) Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 37: 347-352.
60. Shoup M, Hodul P, Aranha GV, Choe D, Olson M, Leya J, et al,. (2000) Defining a role for endoscopic ultrasound in staging periampullary tumors. Am J Surg 179: 453-456.
61. Soriano A, Castells A, Ayuso C, Ayuso JR, de Caralt MT, Gines MA, et al,. (2004) Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 99: 492-501.
62. DeWitt J, Devereaux B, Chriswell M, McGreevy K, Howard T, Imperiale TF, et al,. (2004) Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 141: 753-763.
63. Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, et al,. (1998) Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 170: 1315-1322.
64. Trede M, Rumstadt B, Wendl K, Gaa J, Tesdal K, Lehmann KJ, et al,. (1997) Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors. Ann Surg 226: 393-405. discussion -7.
65. Lee JK, Kim AY, Kim PN, Lee MG, Ha HK,. (2010) Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma. Eur J Radiol 73: 310-316.
66. Park HS, Lee JM, Choi HK, Hong SH, Han JK, Choi BI,. (2009) Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 30: 586-595.
67. Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, et al,. (2007) Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Acta Gastroenterol Belg 70: 331-338.
68. Farma JM, Santillan AA, Melis M, Walters J, Belinc D, Chen DT, et al,. (2008) PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol 15: 2465-2471.
69. Tang S, Huang G, Liu J, Liu T, Treven L, Song S, et al,. (2011) Usefulness of (18)F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis. Eur J Radiol 78: 142-150.
70. Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, et al,. (2007) 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 246: 932-937. discussion 7-9.
71. Artifon EL, Couto D, Jr, Sakai P, da Silveira EB,. (2009) Prospective evaluation of EUS versus CT scan for staging of ampullary cancer. Gastrointest Endosc 70: 290-296.
72. Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L,. (2004) Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 99: 844-850.
73. Miller FH, Rini NJ, Keppke AL,. (2006) MRI of adenocarcinoma of the pancreas. AJR Am J Roentgenol 187: W365-W374.
74. Donahue TR, Isacoff WH, Hines OJ, Tomlinson JS, Farrell JJ, Bhat YM, et al,. (2011) Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery. Arch Surg 146: 836-843.
75. Low G, Panu A, Millo N, Leen E,. (2011) Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. Radiographics 31: 993-1015.
76. Martin DR, Semelka RC,. (2000) MR imaging of pancreatic masses. Magn Reson Imaging Clin N Am 8: 787-812.
77. Vachiranubhap B, Kim YH, Balci NC, Semelka RC,. (2009) Magnetic resonance imaging of adenocarcinoma of the pancreas. Top Magn Reson Imaging 20: 3-9.
78. Bipat S, Phoa SS, van Delden OM, Bossuyt PM, Gouma DJ, Lameris JS, et al,. (2005) Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 29: 438-445.
79. Khan I, Conlon K,. (2009) Pancreatic adenocarcinoma. In:, Garden O, ed. Hepatobiliary and Pancreatic Surgery, 4th edn. Oxford: Elsevier, pp. 283-298.
80. Iglesias Garcia J, Larino Noia J, Dominguez Munoz JE,. (2009) Endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. Rev Esp Enferm Dig 101: 631-638.
81. Barreto S, Shukla P, Shrikhande S,. (2007) Periampullary carcinoma. In:, Shrikhande S, Friess H, Buechler M, eds. Surgery of Pancreatic Tumors. New Delhi: BI publications, pp. 206-215.
82. Goldberg J, Rosenblat J, Khatri G, Schwender B, Kaushik N, Katz D, et al,. (2010) Complementary roles of CT and endoscopic ultrasound in evaluating a pancreatic mass. AJR Am J Roentgenol 194: 984-992.
83. Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG,. (2009) Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era? J Am Coll Surg 208: 87-95.
84. Enestvedt CK, Mayo SC, Diggs BS, Mori M, Austin DA, Shipley DK, et al,. (2008) Diagnostic laparoscopy for patients with potentially resectable pancreatic adenocarcinoma: is it cost-effective in the current era? J Gastrointest Surg 12: 1177-1184.
85. Nieveen van Dijkum EJ, Romijn MG, Terwee CB, de Wit LT, van der Meulen JH, Lameris HS, et al,. (2003) Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 237: 66-73.
86. Aziz AM, Said T, Poovathumkadavil A, Almulla A,. (2010) Using multidetector CT in predicting resectability of pancreatic head tumors: surgical and pathologic correlation. J Egypt Natl Canc Inst 22: 233-239.
87. Olivie D, Lepanto L, Billiard JS, Audet P, Lavallee JM,. (2007) Predicting resectability of pancreatic head cancer with multi-detector CT. Surgical and pathologic correlation. JOP 8: 753-758.
88. Phoa SS, Tilleman EH, van Delden OM, Bossuyt PM, Gouma DJ, Lameris JS,. (2005) Value of CT criteria in predicting survival in patients with potentially resectable pancreatic head carcinoma. J Surg Oncol 91: 33-40.
89. Kaneoka Y, Yamaguchi A, Isogai M,. (2009) Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery 145: 417-425.
90. Shrikhande SV, Barreto SG,. (2010) Extended pancreatic resections and lymphadenectomy: an appraisal of the current evidence. World J Gastrointest Surg 2: 39-46.